Smoking Cessation; Tobacco DependenceNCT06762210
the Effectiveness of AI Molar Mind for Smoking Cessation Through Dental Health Evaluation
A study testing AI Molar Mind in people with Smoking Cessation; Tobacco Dependence, run by Fayoum University at 1 site in Egypt.
Trial summary
Smoking cessation remains a significant public health challenge, with millions of individuals struggling to quit despite available interventions. Read more about this study
- Who is it for?
- Ages 21 to 65 years
- Conditions the study is for
- Smoking Cessation; Tobacco Dependence
- What is being tested?
- AI Molar Mind
- Type of treatment
- Pill or oral medicine
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 300 participants
- Where
- 1 siteEgypt
- Study dates
- 12 Feb 2026to Sep 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 21 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Adults aged 18-65 years
- smoke ≥5 cigarettes per day
- motivated to quit smoking,
- have access to a smartphone or computer
Who cannot join
- Pregnant women
- individuals with severe psychiatric conditions
- those already using other smoking cessation therapies.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Egypt1 site, 1 recruiting
- Recruiting
faculty of Dentistry, Fayoum University
Fayoum, Alexandria Governorate, 21523
Alshaimaa Mohamed, PhD, 00201006047940, aas16@fayoum.edu.eg
About this study
Official title: the Effectiveness of AI Molar Mind for Smoking Cessation Through Dental Health Evaluation: Randomized Control Trial
Smoking cessation remains a significant public health challenge, with millions of individuals struggling to quit despite available interventions.
Read the detailed description
Oral health deterioration is a well-documented consequence of smoking, including periodontal disease, tooth discoloration, and oral cancer. Recent advancements in artificial intelligence (AI) have led to the development of AI Molar Mind, a digital tool designed to assess oral health and provide personalized feedback to motivate behavioral change. This study aims to evaluate the efficacy of AI Molar Mind in aiding smoking cessation by leveraging oral health evaluations as a motivational tool.
- Conditions
- Smoking Cessation; Tobacco Dependence
- Being tested
- AI Molar Mind
- Keywords
- Smoking cessation, oral health
- Medical subject headings
- Smoking Cessation, Tobacco Use Disorder
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
AI Molar MindOther
a baseline oral health assessment using AI Molar Mind, which analyzes intraoral images and self-reported oral health data.
| Study group | Role | What they receive |
|---|---|---|
| AI Molar Mind Group | Experimental | Participants receive a baseline oral health assessment using AI Molar Mind Receives: Other: AI Molar Mind |
| Control group | No intervention | Participants receive standard smoking cessation care |
What is being measured
The primary outcome is the main question the study is designed to answer.
smoking cessation indicator
Biochemically verified smoking cessation at 6 months (measured by exhaled carbon monoxide levels <6 ppm).
Measured: base line, 6-month post smoking cessation
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Jan 2025
- Study start12 Feb 2026
- Primary completionMay 2026 (estimated)
- Study completionSep 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Smoking Cessation; Tobacco DependenceStudies of the same condition, open and under way.
- More trials run by Fayoum UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- A randomized, controlled, single-blind clinical trial with two parallel arms.
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 300 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Fayoum University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Alshaimaa Ahmed shabaan, Fayoum University
- Investigators
- Alshaimaa Mohamed, PhD, Principal investigator, Fayoum University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06762210
- Sponsor's protocol ID
- Oral health assessment AI
- Status last verified
- Feb 2026
- First submitted
- 1 Jan 2025
- Last updated
- 20 Feb 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Oya-Watanabe Y, Inagaki K, Nimi T, Yamamoto Y, Tanabe T, Okai M, Segawa N, Watanabe T, Uchibori N, Koide T, Inukai J, Yuasa H, Mitani A, Nagao T, Fukui M, Hinode D. Attitudes toward smoking cessation according to smoking status among dentists in the Aichi Dental Association in Japan. Tob Induc Dis. 2024 Aug 6;22. doi: 10.18332/tid/191290. eCollection 2024.
PubMed 39109252Herpich TL, Mendes EM, Roxo-Goncalves M, Katz N, Almeida JD, Martins MD, Romanini J, Carrard VC. Impact of an educational intervention regarding tobacco counseling on dentists and dental students. Braz Oral Res. 2024 Nov 8;38:e102. doi: 10.1590/1807-3107bor-2024.vol38.0102. eCollection 2024.
PubMed 39536203
Study at a glance
From the registry record, last updated by the sponsor on 20 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- the Effectiveness of AI Molar Mind for Smoking Cessation Through Dental Health Evaluation: Randomized Control Trial
- ClinicalTrials.gov ID
- NCT06762210
- Acronym / sponsor ID
- Oral health assessment AI
- Conditions
- Smoking Cessation; Tobacco Dependence
- Keywords
- Smoking cessation, oral health
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 300 participants (estimated)
- Lead sponsor
- Fayoum UniversityUniversity, hospital or other
- Study start
- 12 Feb 2026 (actual)
- Primary completion
- May 2026 (estimated)
- Study completion
- Sep 2026 (estimated)
- First posted
- 7 Jan 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Smoking cessation remains a significant public health challenge, with millions of individuals struggling to quit despite available interventions.
Detailed description
Oral health deterioration is a well-documented consequence of smoking, including periodontal disease, tooth discoloration, and oral cancer. Recent advancements in artificial intelligence (AI) have led to the development of AI Molar Mind, a digital tool designed to assess oral health and provide personalized feedback to motivate behavioral change. This study aims to evaluate the efficacy of AI Molar Mind in aiding smoking cessation by leveraging oral health evaluations as a motivational tool.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- A randomized, controlled, single-blind clinical trial with two parallel arms.
| Arm | Type | Receives |
|---|---|---|
| AI Molar Mind Group | Experimental | Other: AI Molar MindParticipants receive a baseline oral health assessment using AI Molar Mind |
| Control group | No intervention | –Participants receive standard smoking cessation care |
Who may qualify
- Ages
- 21 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Adults aged 18-65 years
- smoke ≥5 cigarettes per day
- motivated to quit smoking,
- have access to a smartphone or computer
Key exclusion criteria (3 listed)
- Pregnant women
- individuals with severe psychiatric conditions
- those already using other smoking cessation therapies.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| AI Molar Minda baseline oral health assessment using AI Molar Mind, which analyzes intraoral images and self-reported oral health data. | Other | AI Molar Mind Group |
Primary outcome
smoking cessation indicator
Time frame: base line, 6-month post smoking cessation
Biochemically verified smoking cessation at 6 months (measured by exhaled carbon monoxide levels <6 ppm).
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Feb 2026.
- Background: PubMed 39109252Oya-Watanabe Y, Inagaki K, Nimi T, Yamamoto Y, Tanabe T, Okai M, Segawa N, Watanabe T, Uchibori N, Koide T, Inukai J, Yuasa H, Mitani A, Nagao T, Fukui M, Hinode D. Attitudes toward smoking cessation according to smoking status among dentists in the Aichi Dental Association in Japan. Tob Induc Dis. 2024 Aug 6;22. doi: 10.18332/tid/191290. eCollection 2024.
- Background: PubMed 39536203Herpich TL, Mendes EM, Roxo-Goncalves M, Katz N, Almeida JD, Martins MD, Romanini J, Carrard VC. Impact of an educational intervention regarding tobacco counseling on dentists and dental students. Braz Oral Res. 2024 Nov 8;38:e102. doi: 10.1590/1807-3107bor-2024.vol38.0102. eCollection 2024.
- Individual participant dataSharing planned: No
Related trials for Smoking Cessation; Tobacco Dependence
Recruiting
Young Adult Tobacco/Nicotine and Cannabis Co-use
Tobacco Use Disorder, Nicotine Dependence
Recruiting
Social Media Support Groups for Adolescent Vaping Cessation
Vaping, Vaping Cessation
RecruitingObservational study
§SMOKE Nicotine and Tobacco Youth Cohort
Tobacco Use Behavior, Nicotine Dependence Tobacco Product
Active, not recruitingPhase 3
Early Withdrawal Exposure and Negative Affect Withdrawal (NAW) Regulation Training for Smoking Cessation
Tobacco Dependence
Not yet recruiting
Quit With Sense: Using Mindful Smoking and Wearable Device for Smoking Cessation
Smoking Cessation, Cigarette Smoking
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Alshaimaa Mohamed, PhD principal investigator
Fayoum University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing AI Molar Mind in people with Smoking Cessation; Tobacco Dependence, run by Fayoum University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 20 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Alshaimaa shabaan, PhD (00201006047940, aas16@fayoum.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
smoking cessation indicator (time frame: base line, 6-month post smoking cessation). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06762210, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Feb 2026.